Glucocorticoids and Risk of Venous Thromboembolism in Asthma Patients Aged 20–59 Years in the United Kingdom’s CPRD 1995–2015

BACKGROUND: Glucocorticoids, the class of steroids used in management of asthma, have been observed to be associated with adverse events such as increased coagulation and inhibition of fibrinolysis. This study evaluated the risk of VTE in relation to the use of glucocorticoids in patients with asthm...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayodele, Olulade A, Cabral, Howard J, McManus, David D, Jick, Susan S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786344/
https://www.ncbi.nlm.nih.gov/pubmed/35082533
http://dx.doi.org/10.2147/CLEP.S341048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786344/
https://www.ncbi.nlm.nih.gov/pubmed/35082533
http://dx.doi.org/10.2147/CLEP.S341048

Ejemplares similares